Pharmaceutical Executive Europe - August 2008 - (Page 5)

Pharmaceutical Executive Europe August 2008 From the Editor 5 A Summer Lull? W hether you’re working in the European pharmaceutical industry, directly in association with it, or somewhere on the periphery, you’ll know only too well that getting in touch with senior people can become a little tricky in the hot summer months of July and August. This is much more the case when you’re trying to reach your French or southern European colleagues, who are the most likely to have a) a lengthy vacation and b) decent weather. Things slow down a little here in the UK too, but generally we can only look on in envy as European executives enjoy their time out in the sun (especially as summer in the UK appears to have been cancelled for the second year running.) But the summer slowdown shouldn’t lull us into a false sense of relaxation, because July has still been quite a month for pharma activity. In the UK alone, the last four weeks has seen a potential Alzheimer’s breakthrough hit the news (TaurX’s Rember, the results of which set the Alzheimer’s Association International Conference a-buzz in Chicago); announcements on cost-cutting and a focus shift away from prescription drugs from GSK’s new CEO Andrew Witty; and the six-month suspension of Roche UK from the Association of the British Pharmaceutical Industry (ABPI) for “serious breaches” of the Association’s Code of Practice. Needless to say, we touch on those stories, and plenty more, in this issue of PEE. In addition, our interview this month (with EuroBio’s commissioner general Eric Poincelet) looks forward to the new event season, which will be upon us again in just a few weeks. As the activity steps up a gear, we will, as ever, be along for the ride. In September we bring you a new, easier-to-read, faster-to-navigate digital format. Hopefully, this will serve your needs even more effectively, as you keep up with the ever-quickening pace of the industry. Pharmaceutical Executive Advancing business leadership Pharmaceutical Executive Europe provides industry intelligence so managers in the European pharmaceutical community can advance their business, management and marketing practices to gain competitive advantage. PEE interprets the current and future challenges the industry faces and enables pharmaceutical professionals to overcome them with cost-effective, time-saving solutions. Group Publisher Andy Davies Tel. +44 1244 393 408 adavies@advanstar.com Editorial Director Peter Houston Tel. +44 1244 393 435 phouston@advanstar.com Editor Julian Upton jupton@advanstar.com Marketing Manager Sally Carron scarron@advanstar.com North American Sales Manager John J. Currid jcurrid@advanstar.com Sales Support Claire Rice crice@advanstar.com Graphic Designer Ian Williams iwilliams@advanstar.com Production Director Jo Armstrong jarmstrong@advanstar.com Advanstar Communications (U.K.) Ltd Corporate Office Advanstar Communications Inc. 7500 Old Oak Boulevard Cleveland OH 44130, USA Advanstar Communications Inc. Chief Executive Officer Joseph Loggia Chief Financial Officer Theodore S. Alpert Chief Marketing Officer Patricia Joseph Executive VP, Corporate Development Eric I. Lisman VP, Treasurer & Controller Shelbie O’Brien VP, Publishing Operations Francis Heid VP, Human Resources Nancy Nugent VP, Chief Technology Officer Rick Treese VP, Marketing & Communications Georgiann Decenzo Subscribe online at www.pharmexeceurope.com VP, General Counsel Ward Hewins Pharmaceutical Executive Europe is free to qualified subscribers in Europe. To apply for a free subscription, or to change your name or address, go to www.pharmexeceurope.com, click on Subscribe, & follow the prompts. To cancel your subscription or to order back issues, please email your request to magazines@superfill.com, putting PEE in the subject line. Please quote your subscription number if you have it Non-qualified readers in Europe Readers outside Europe 1 year (8 issues) £100 £140 2 years (16 issues) £170 £240 Current issue: Back issue: £20 £35 Copyright ©2008. Advanstar Communications (UK) Ltd. All rights reserved. No part of this publication may be reproduced in any material form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner except in accordance with the provisions of the Copyright, Designs & Patents Act (UK) 1988 or under the terms of a licence issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP UK. , Applications for the copyright owner’s permission to reproduce any part of this publication should be forwarded in writing to Permissions Dept, Advanstar Communications (UK) Ltd, Advanstar House, Park West, Sealand Road, Chester CH1 4RN, UK. Warning: The doing of an unauthorized act in relation to a copyright work may result in both a civil claim for damages and criminal prosecution. Julian Upton jupton@advanstar.com Editorial Advisory Board Pharmaceutical Executive Europe’s Editorial Advisory Board (EAB) is a distinguished group of specialists who represent various facets of the pharmaceutical industry. EAB members suggest article subjects relevant to the industry, review article manuscripts, participate in events and answer questions as they arise. Executive/Strategy David Barratt CEO, Euro RSCG Life UK Dr Brian Smith Visiting Fellow, Open University and CEO, Pragmedic Medical Education Peter George CEO, Penn Pharmaceutical Services CSR Branding Rebecca Robins Global Marketing Director, Interbrand Healthcare Clinical Trials Nathan Waller Director, Account Management, PAREXEL International Francis P. Crawley Executive Director Good Clinical Alliance Practice, Europe Biopartnering Gerhard Symons Doctoral Researcher, Tanaka Business School, Imperial College, London Information Management George Laszlo Managing Director Laszlo Consulting Business/Marketing Keith Allan Head of Global Product Advocacy, Novartis Pharma Supply Chain Julian Mount Senior Director, Head of European Trade, Pfizer http://www.pharmexeceurope.com http://www.pharmexeceurope.com,

Table of Contents for the Digital Edition of Pharmaceutical Executive Europe - August 2008

Pharmaceutical Executive Europe - August 2008
Contents
From the Editor
News and Analysis
Calendar
The Calm Before the Storm
Steering Pharma in Russia
Built on Sand
Renaissance Man
IT Meets IMI
Send for the Software Specialists
Know Your eMarket
Last Words

Pharmaceutical Executive Europe - August 2008